您的当前位置:首页 > 行业数据 > anti-FGFR2b单抗与SOS1抑制剂国内临床进展
图片属性
图片格式:PNG 图片大小:195KB 图片尺寸:2350*791
同报告图片
 / 4
anti-FGFR2b单抗与SOS1抑制剂国内临床进展_第1页
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
anti-FGFR2b单抗与SOS1抑制剂国内临床进展_第2页
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
anti-FGFR2b单抗与SOS1抑制剂国内临床进展_第3页
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
anti-FGFR2b单抗与SOS1抑制剂国内临床进展_第4页
anti-FGFR2b单抗与SOS1抑制剂国内临床进展_第5页
所属报告: ST人福(600079)-A股公司研究报告:麻药优势突出的综合药企招商入主开启归核创新篇章-251229(32页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠